[Federal Register Volume 86, Number 10 (Friday, January 15, 2021)]
[Notices]
[Pages 4080-4081]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00870]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2021-0002]


Advisory Committee on Immunization Practices (ACIP)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting of the Advisory Committee on Immunization Practices 
(ACIP). This meeting is open to the public. Time will be available for 
public comment. The meeting will be webcast live via the World Wide 
Web.

DATES: The meeting will be held on January 27, 2021 from 10:00 a.m. to 
5:00 p.m., EST (times subject to change, see the ACIP website for any 
updates: http://www.cdc.gov/vaccines/acip/index.html).
    Written comments must be received on or before January 27, 2021.

ADDRESSES: For more information on ACIP please visit the ACIP website: 
http://www.cdc.gov/vaccines/acip/index.html.
    You may submit comments, identified by Docket No. CDC-2021-0002 by 
any of the following methods:
    <bullet> Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
    <bullet> Mail: Docket No. CDC-2021-0002, c/o Attn: January 27, 2021 
ACIP Meeting, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H24-8, Atlanta, GA 30329-4027.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    Written public comments submitted 24 hours prior to the ACIP 
meeting will be provided to ACIP members before the meeting.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367; 
Email: <a href="/cdn-cgi/l/email-protection#7233313b22321116115c151d04"><span class="__cf_email__" data-cfemail="4e0f0d071e0e2d2a2d60292138">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: In accordance with 41 CFR 102-3.150(b), less 
than 15 calendar days' notice is being given for this meeting due to 
the exceptional circumstances of the COVID-19 pandemic and rapidly 
evolving COVID-19 vaccine development and regulatory processes. The 
Secretary of Health and Human Services has determined that COVID-19 is 
a Public Health Emergency.
    Purpose: The committee is charged with advising the Director, CDC, 
on the

[[Page 4081]]

use of immunizing agents. In addition, under 42 U.S.C. 1396s, the 
committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines for Children (VFC) program, 
along with schedules regarding dosing interval, dosage, and 
contraindications to administration of vaccines. Further, under 
provisions of the Affordable Care Act, section 2713 of the Public 
Health Service Act, immunization recommendations of the ACIP that have 
been approved by the Director of the Centers for Disease Control and 
Prevention and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters to be Considered: The agenda will include discussions on 
COVID-19 vaccines. No recommendation vote is scheduled for COVID-19 
vaccines. Agenda items are subject to change as priorities dictate. For 
more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web; for more information on ACIP please visit the ACIP website: 
http://www.cdc.gov/vaccines/acip/index.html.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting materials 
are part of the public record and are subject to public disclosure. Do 
not include any information in your comment or supporting materials 
that you consider confidential or inappropriate for public disclosure. 
If you include your name, contact information, or other information 
that identifies you in the body of your comments, that information will 
be on public display. CDC will review all submissions and may choose to 
redact, or withhold, submissions containing private or proprietary 
information such as Social Security numbers, medical information, 
inappropriate language, or duplicate/near duplicate examples of a mass-
mail campaign. CDC will carefully consider all comments submitted into 
the docket. CDC does not accept comment by email.
    Written Public Comment: Written comments must be received on or 
before January 27, 2021. Oral Public Comment: This meeting will include 
time for members of the public to make an oral comment. Oral public 
comment will occur before any scheduled votes including all votes 
relevant to the ACIP's Affordable Care Act and Vaccines for Children 
Program roles. Priority will be given to individuals who submit a 
request to make an oral public comment before the meeting according to 
the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the January 27, 2021 ACIP meeting must submit 
a request at http://www.cdc.gov/vaccines/acip/meetings/ no later than 
11:59 p.m., EST, January 25, 2021 according to the instructions 
provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by January 26, 2021. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to 3 minutes, and each speaker 
may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-00870 Filed 1-12-21; 4:15 pm]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>